Eledon Pharmaceuticalsincis A Clinical Stage Biotechnology Company Based In Irvinecaliforniathe Company Focuses On Developing Immune Modulating Therapies For Serious Conditionsparticularly In Transplantation And Neurodegenerative Diseaseseledon S Mission Is To Enableone Transplant For Life Aiming To Enhance Organ Longevity And Improve The Quality Of Life For Patientsthe Company Employs Around 31 Individuals Eledon Specializes In Therapies That Target The Cd40 Cd40L Costimulatory Pathwaywhich Plays A Crucial Role In Regulating Immune Responsesits Key Producttegoprubartis An Anti Cd40L Monoclonal Antibody Designed To Prevent Organ Rejection In Kidneyliverand Islet Cell Transplantsas Well As To Address Conditions Like Amyotrophic Lateral Sclerosisalsand Certain Autoimmune Diseasesthe Company Is Committed To Advancing Its Clinical Trials And Optimizing The Safety And Effectiveness Of Its Therapies
